Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 04.05.2026 FVD. IE00BKVKW020 250,002.00 USD 7,221,030.17 28.884 ...
-
Cummins Delivered Strong Operating Results and Returned $519 Million to Shareholders in the First Quarter of 2026; Raises Full-year Outlook
COLUMBUS, Ind.--(BUSINESS WIRE)--Cummins Inc. (NYSE: CMI) today reported results for the first quarter of 2026. “Cummins delivered strong results in the first quarter, led by record performance in our Power Systems segment. Our teams executed with discipline to meet continued strong demand for data center backup power and North America truck markets began to improve from a cyclical low,” said Jennifer Rumsey, Chair and CEO of Cummins. “We also recorded charges related to the sale of our low-pre...
-
Zywave Unveils Spring 2026 Release to Help Brokers Work Smarter Across Every Workflow to Drive Growth
MILWAUKEE--(BUSINESS WIRE)--Zywave’s Spring 2026 Release enhances connected workflows to help brokers reduce manual work, accelerate selling, and drive growth....
-
Valvoline Inc. Becomes the First Ronald McDonald House Global Corporate Partner Dedicated Solely to Funding Mental Health Initiatives
LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced it is becoming the first Ronald McDonald House Global corporate partner dedicated solely to funding mental health initiatives. Representing a $750,000 total commitment over three years, the partnership reflects a shared dedication to strengthening families and improving health outcomes in communities across the United States. In year one, Valvoline I...
-
Cambridge Financial Group, Inc. and First Seacoast Bancorp, Inc. Agree to Merge
CAMBRIDGE, Mass. & DOVER, N.H.--(BUSINESS WIRE)--Cambridge Financial Group, Inc. (“Cambridge Financial”), the mutual holding company of Cambridge Savings Bank, and First Seacoast Bancorp, Inc. (“First Seacoast Bancorp”) (Nasdaq: “FSEA”), the holding company of First Seacoast Bank, jointly announced today they have entered into a definitive merger agreement under which First Seacoast Bancorp will merge with Cambridge Financial, with Cambridge Financial as the surviving corporation, and First Sea...
-
Procore Announces First Quarter 2026 Financial Results
CARPINTERIA, Calif.--(BUSINESS WIRE)--Procore Technologies, Inc. (NYSE: PCOR), the leading global provider of construction management software, today announced financial results for the first quarter ended March 31, 2026. "We delivered strong Q1 financials," said Ajei Gopal, President and CEO of Procore. "That performance, which exceeded the high end of our guidance, gives us even more confidence in the future, enabling us to increase our full-year outlook. I am particularly pleased that we hav...
-
Sphere Entertainment Co. Reports First Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Sphere Entertainment Co. (NYSE: SPHR) (“Sphere Entertainment” or the “Company”) today reported financial results for the first quarter ended March 31, 2026. Recent highlights for the Company’s Sphere segment include: Plans to bring Sphere to Abu Dhabi and National Harbor continue to move forward, while the Company also remains in discussions with a significant number of markets globally regarding additional large and smaller-scale Sphere venues; The Wizard of Oz at Sp...
-
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company, announced today that the first patient was dosed in Study FTH-PIK-101 (NCT07558733), a Phase 1b/2 trial of PIKTOR in patients with HR+/HER2- advanced breast cancer. PIKTOR, an investigational, all-oral combination of serabelisib and sapanisertib, is designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway through PI3K-alpha and dual mTORC1/2 targeting, and became Sensei's lead pr...
-
Fortive To Present at 2026 Wolfe Research 19th Annual Global Transportation & Industrials Conference
EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that Olumide Soroye, President and Chief Executive Officer, and Mark Okerstrom, Chief Financial Officer, will be presenting at the 2026 Wolfe Research 19th Annual Global Transportation & Industrials Conference on Tuesday, May 19th, 2026, at 10:55 a.m. ET. The audio will be simultaneously webcast and archived on the "Investors" section of Fortive’s website, www.fortive.com. About Fortive Fortive inno...
-
NEUPATH HEALTH TO REPORT Q1 2026 RESULTS AND HOST INVESTOR WEBINAR
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, today announced that it will release its interim financial results for the quarter ended March 31, 2026 before markets open on Thursday, May 14, 2026. Investors and stake...